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Lung injuryApart from control of circulating ﬂuid, atrial natriuretic peptide (ANP) exhibits anti-inﬂammatory effects in the
lung. However,molecularmechanisms of ANP anti-inﬂammatory effects are notwell-understood. Peripheralmi-
crotubule (MT) dynamics is essential for agonist-induced regulation of vascular endothelial permeability. Here
we studied the role ofMT-dependent signaling in ANP protective effects against endothelial cell (EC) barrier dys-
function and acute lung injury induced by Staphylococcus aureus-derived peptidoglican-G (PepG). PepG-induced
vascular endothelial dysfunction was accompanied byMT destabilization and disruption of MT network. ANP at-
tenuated PepG-induced MT disassembly, NFκB signaling and activity of MT-associated Rho activator GEF-H1
leading to attenuation of EC inﬂammatory activation reﬂected by expression of adhesion molecules ICAM1 and
VCAM1. ANP-induced EC barrier preservation andMT stabilization were linked to phosphorylation and inactiva-
tion of MT-depolymerizing protein stathmin. Expression of stathmin phosphorylation-deﬁcient mutant
abolished ANP protective effects against PepG-induced inﬂammation and EC permeability. In contrast, siRNA-
mediated stathmin knockdownprevented PepG-induced peripheralMT disassembly and endothelial barrier dys-
function. ANP protective effects in a murine model of PepG-induced lung injury were associated with increased
phosphorylation of stathmin, while exacerbated lung injury in the ANP knockout mice was accompanied by de-
creased pool of stableMT. Stathmin knockdown in vivo reversed exacerbation of lung injury in the ANP knockout
mice. These results show a novel MT-mediated mechanism of endothelial barrier protection by ANP in pulmo-
nary EC and animal model of PepG-induced lung injury via stathmin-dependent control of MT assembly.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Increased lung capillary leak and reduced alveolar liquid clearance
capacity provoked bymany pathologic factors including bacterial patho-
gens represent the major pathologic mechanisms of ﬂuid accumulation
in alveolar space. As a result, pulmonary edema combinedwith increased
inﬂammatory cell inﬁltration in the lung leads to a life-threatening com-
plication, the acute respiratory distress syndrome. Peptidoglycan (PepG)
and lipoteichoic acid are two major cell wall components in gram-
positive bacteria which stimulate inﬂammatory responses in vivo anchoalveolar lavageﬂuid; cAMP,
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(A.A. Birukova).in vitro via activation of toll-like receptors (TLRs) [1,2]. Of the ten TLRs
known, only TLR2 has been clearly shown to be involved in the host de-
fense against gram-positive bacteria [3,4]. Activation of TLR2 in endothe-
lial cells leads to phosphorylation/activation of downstream targets
including mitogen-activated protein kinases (MAPK) p42/p44, JNK1/2,
and p38, nuclear factor kappa-B (NFκB) pathway [5]. Consistent with
its key role in mediating inﬂammatory signaling from Gram-positive
bacteria, siRNA-induced knockdown of TLR-2 decreased Raf phosphory-
lation and suppressed TLR2-mediated activation of Raf-MEK1/2-ERK1/2-
IKK-NFκB cascade [6]. Increasing evidence suggests that, in addition to its
role in body ﬂuid control, atrial natriuretic peptide (ANP) exhibits direct
anti-inﬂammatory and barrier effects on vascular endothelium which
were demonstrated in the models of endothelial hyper-permeability in-
duced by hypoxia, lysophospholipids and inﬂammatory mediators [7,8].
The two major ANP receptors, NPR-A and NPR-B act as membrane-
associated guanylate cyclases [9], and elevation of cGMP levels is a pri-
mary response to ANP stimulation. ANP-induced elevation of cGMP de-
creased basal levels of lung EC permeability, attenuated pulmonary EC
barrier dysfunction caused by hydrogen peroxide [10,11], and inhibited
oxidant-induced pulmonary edema observed in perfused rabbit lungs
[12]. However, ANP-mediated elevation of cGMP increased lung vascu-
lar permeability in the ischemia reperfusion model of lung injury [13],
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models. Several reports also indicate the involvement of cAMP and
cAMP-dependent protein kinase (PKA) in physiological responses elicit-
ed by ANP [14,15] including EC barrier protective effects mediated by
Epac-Rap1-Rac1 signaling pathway [8]. The other report demonstrated
PKA-independent activation of Rap1 by both cAMP and cGMP analogs
and suggests activation of barrier protective Rap1 signaling through a
cAMP/cGMP-regulated guanine nucleotide exchange factor [16]. ANP
anti-inﬂammatory effects have been associated with attenuation of
stressMAP kinase andNFκB cascade activities and RhoGTPase signaling
[17,18], but precise molecular mechanisms of ANP-dependent attenua-
tion of these pro-inﬂammatory pathways are not well-understood.
Regulation of vascular endothelial barrier is achieved via dynamic
actin cytoskeletal remodeling in vascular endothelial cells (EC) coordi-
nated with assembly and disassembly of cell-cell junctions [19]. Emerg-
ing evidence also indicates a critical role of crosstalk between actin
networks andmicrotubules (MT) in precise regulation of EC permeabil-
ity by chemical and mechanical factors [20,21]. MT-associated guanine
nucleotide exchange factor H1 (GEF-H1) has been implicated in the
MT-dependent regulation of Rho activity. In the MT-bound state, the
nucleotide exchange activity of GEF-H1 is suppressed, whereas GEF-
H1 release caused by MT disruption stimulates GEF-H1 [22].
MT dynamics controls many cellular processes includingmitosis, lo-
comotion, protein and organelle transport and permeability [23]. MT
growth is regulated by a number of MT-associated proteins which con-
trol polymerization, depolymerization rates and MT stability. Stathmin
is a regulator of MT dynamics which is expressed in endothelial cells
and other cell types. In the unphosphorylated state, stathmin promotes
MT destabilization by sequestration of soluble tubulin and by direct MT
binding, which promotes MT shortening. Stathmin phosphorylation on
one or more serine residues by PKA, Rac effector kinase PAK1 or other
kinases reduces its MT-destabilizing activity [24]. This study elucidated
the role of MT-dependent signaling in the EC barrier dysfunction and
inﬂammatory activation induced by PepG in vitro and in vivo. We inves-
tigated the molecular mechanism of barrier-protective and anti-
inﬂammatory effects of ANP via stathmin-mediated control of MT dy-
namics and MT-associated modulation of signaling pathways leading
to EC permeability, inﬂammation and PepG-induced lung injury.
2. Materials and methods
2.1. Cell culture and reagents
Human pulmonary artery endothelial cells (HPAEC) were obtained
from Lonza (East Rutherford, NJ) and used for experiments at passages
5-8. ANP and TRAP6 were purchased from Ana Spec (San Jose, CA). Re-
agents for immunoﬂuorescence were purchased from Molecular Probes
(Eugene, OR). HRP-linked anti-mouse and -rabbit IgG antibodies were
obtained from Cell Signaling Inc. (Beverly, MA). Antibodies to phospho-
myosin phosphatase targeting subunit1 (MYPT), GEF-H1, diphospho-
myosin light chain (MLC), phospho-stathmin, and IκBα were from Cell
Signaling Inc (Beverly, MA); stathmin and End-Binding protein-1 (EB1)
were from BD Transduction Laboratories (San Diego, CA); ICAM-1 and
VCAM-1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Peptido-
glycan G (PepG) polymer covers cell surface of S. aureus Gram positive
bacteria. PepG of 99% purity isolated from S. aureus, cat-77140, was ob-
tained from Fluka (Buchs, Switzerland). Unless speciﬁed, other biochem-
ical reagents including β-Tubulin and acetylated tubulin antibodieswere
obtained from Sigma (St. Louis, MO).
2.2. siRNA and DNA transfections
To deplete endogenous stathmin, pre-designed human or mouse
Stealth™ Select siRNA sets of standard purity were ordered from
Invitrogen (Carlsbad, CA). Transfection of pulmonary EC culture with
siRNA was performed as previously described [20]. Nonspeciﬁc, non-targeting siRNA (nsRNA) was used as a control treatment. After 72 h
of transfection, cells were used for experiments or harvested for west-
ern blot veriﬁcation of speciﬁc protein depletion. For in vivo experi-
ments, we used polymer-based administration of non-speciﬁc or
speciﬁc siRNA conjugated with polycation polyethilenimine PEI-22 as
described in our previous studies [20,25]. Plasmid encoding stathmin-
S63A mutant bearing a His-tag was provided by G. Bokoch (Scripps, La
Jolla, CA) and was used for transient transfections of human pulmonary
EC cultures according to protocols described elsewhere [20]. Control
transfections were performed with empty vectors.
2.3. Cell imaging
Endothelialmonolayers plated on glass cover slipswere subjected to
immunoﬂuorescence staining with Texas Red phalloidin to visualize F-
actin as previously described [20]. Quantitative analysis of paracellular
gap formation in EC monolayers treated with ANP and PepG was per-
formed as previously described [26].For microtubule quantiﬁcation,
cells were ﬁxedwith -20 ° Cmethanol and immunostainingwas carried
outwithβ-tubulin or EB1 antibodies as described previously [27]. Brief-
ly, after the cell boundarieswere outlined, the concentric outline shapes
reduced to 70% were applied to the images to mark peripheral (outer
30% of diameter) and central (inner 70% of diameter) regions. The inte-
grated ﬂuorescence density in the peripheral area was measured using
MetaMorph software and was calculated as a percentage of the inte-
grated ﬂuorescence density in the total cell area. The results were nor-
malized in each experiment. Similar methods were applied to EB1
quantiﬁcation in ﬁxed cells except that EB1 immunoreactivity was
manually counted and results were not normalized. Minimum 10 cells
per condition, in three experimental repeats were analyzed.
2.4. Measurement of EC permeability
The Express permeability testing assay (XPerT) was recently devel-
oped in our group [28] and now available fromMillipore (Vascular Per-
meability Imaging Assay, cat. #17-10398). This assay is based on high
afﬁnity binding of avidin-conjugated FITC-labeled tracer to the biotinyl-
ated extracellularmatrix proteins immobilized on the bottom of culture
dishes. Permeability assays were performed in 96-well plates, and the
ﬂuorescence of matrix-bound FITC-avidin was measured on Victor X5
Multilabel Plate Reader (Perkin Elmer, Waltham, MA). In permeability
visualization experiments, cells were ﬁxedwith 3.7% formaldehyde. Im-
ages were acquired using Nikon video imaging system Eclipse TE 300
(Nikon, Tokyo, Japan) equipped with a digital camera (DKC 5000,
Sony, Tokyo, Japan); 40× objective lenseswere used. Imageswere proc-
essed with Adobe Photoshop 7.0 software (Adobe Systems, San Jose,
CA). Measurements of transendothelial electrical resistance (TER)
across conﬂuent HPAEC monolayers were performed using the electri-
cal cell-substrate impedance sensing system (ECIS) (Applied Biophysics,
Troy, NY) as previously described [29].
2.5. GEF-H1 activation assay
Plasmid encoding GST-tagged RhoA(G17A) mutant for bacterial ex-
pression was a generous gift from K. Szaszi (St. Michael’s Hospital, To-
ronto, Canada). Active GEF-H1 was precipitated from cell lysates as
previously described [30] using agarose beads with conjugated GST-
tagged RhoA(G17A) mutant which cannot bind nucleotide and there-
fore has high afﬁnity for activated GEFs [31]. Activated GEF-H1 in
RhoA(G17A) pulldowns was detected byWestern blotting and normal-
ized to total GEF-H1 in cell lysates for each sample.
2.6. Microtubule reassembly assay and immunoblotting
ConﬂuentHPAECwere stimulatedwith the agonist of interest for de-
sired periods of time. MT disassembly was promoted by incubating of
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transferred toa 37 °C CO2 incubator for 10 min or 20 min. To analyze
content of assembled MT in control and treated samples, the cells
were washed with PBS and scraped into extraction buffer (100 mM
Pipes, 1 mM EGTA, 1 mMMgSO4, 2 M glycerol, pH 6.75) with protease
and phosphatase inhibitor cocktail and passed several times through a
26-G needle. The cytosolic fraction containing soluble tubulin and the
pellet fraction containing insoluble tubulin (assembled MT) were sepa-
rated by centrifugation at 12000 rpm for 15 min. Protein extracts were
separated by SDS-PAGE, transferred to nitrocellulose membrane, and
probed with speciﬁc antibodies as previously described [32]. Equal
protein loading was veriﬁed by reprobing membranes with antibody
to β-tubulin or the speciﬁc protein of interest.C
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Fig. 1. ANP attenuates PepG-induced EC permeability and actin remodeling. HPAEC grown in 96-w
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bar= 10 μm. D: Bar graphs depict quantitative analysis of total gap area in control, PepG and ANP2.7. In vivo model of acute lung injury and ANP knockout mice
All animal care and treatment procedures were approved by the
University of Chicago Institutional Animal Care and Use Committee
and were handled according to the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. Mice with targeted disrup-
tion of ANP gene (strain B6.129P2-Nppatm1Unc/J) were purchased from
the Jackson Laboratories (Bar Harbor, ME). Genotyping of Nppa−/−
mice was performed by PCR analysis of genomic DNA extracted from
tail snipswith assistance of the animal core facility. Adultmale homozy-
gous Nppa−/− and matched wild type controls, 8–10 week old, with
average weight 20–25 g (Jackson Laboratories, Bar Harbor, ME) were
anesthetized, and PepG (2.5 mg/kg) was administered intratracheallyANP + PepG
ANP + PepG
ell plates (A) or on glass coverslips (B, bar= 10 μm) with immobilized biotinylated gelatin
25 μg/ml, 6 h), and addition of FITC-avidin (25 μg/ml, 3 min). Unbound FITC-avidin was re-
b 0.05 vs. PepG alone. C: EC grown on glass coverslips were pretreated with ANP (100 nM,
ith Texas Red phalloidin to detect actin ﬁlaments. Intercellular gaps are shown by arrows;
+ PepG treated ECmonolayers; data are expressed as mean+ SD; *P b 0.05 vs. PepG alone.
107Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119with or without intravenous ANP (2 μg/kg) injection. At 24 h, animals
were sacriﬁced by exsanguination under anesthesia and cell count
and protein concentration were measured in bronchoalveolar lavage
ﬂuid (BAL) [33]; myeloperoxidase (MPO) content was determined in
lung tissue lysates [34]. Evans blue dye (30 ml/kg) was injected into
the external jugular vein 2 h before termination of ventilation to as-
sess vascular leak as previously decribed [34]. Histological assessment
of lung injury was performed as described elsewhere [33]. Protein
levels of ICAM-1, phospho-stathmin, total and acetylated tubulin inB
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test, were used. P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. ANP protects pulmonary EC monolayers against PepG-induced barrier
disruption
Effects of PepG and ANP on pulmonary EC permeability for
macromolecules were tested in a novel permeability assayA
B
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bar= 5 μm. Insets showhighmagniﬁcation images of cell periphery areaswith EB1-positivemi
monolayers; data are expressed as mean + SD; *P b 0.05, ANP + PepG vs. PepG.(XPerT) recently developed by our group [28]. PepG signiﬁcantly
increased EC monolayer permeability for FITC-labeled avidin,
while ANP attenuated barrier disruptive effects of PepG (Fig. 1A).
Visualization of permeability sites in the PepG-challenged EC
monolayers showed penetration of ﬂuorescent probe via weak-
ened cell-cell junctions and PepG-induced paracellular gaps. ANP
pretreatment of EC monolayers prior to PepG challenge markedly
decreased penetration of FITC-labeled avidin through intercellular
junctions (Fig. 1B). PepG-induced hyper-permeability was accom-
panied by formation of actin stress ﬁbers and intercellular gapsVehicle
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109Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119observed after 5 h of PepG challenge. The barrier disruptive effects
of PepG were attenuated by cell pretreatment with ANP (Fig. 1C
and D).3.2. ANP attenuates the PepG-induced activation of the inﬂammatory
cascade and Rho-dependent signaling
PepG stimulation caused time-dependent activation of inﬂammato-
ry signaling in pulmonary EC reﬂected by a decreased level of inhibitory
NFκB complex subunit, IκBα, and increased protein expression of EC
adhesion molecules ICAM-1 and VCAM-1. Activation of inﬂammatory
molecules 2-24 h after PepG administration was also accompanied by
increased phosphorylation of Rho GTPase targets, myosin phosphatase
targeting subunit1 (MYPT) and myosin light chain (MLC). (Fig. 2AD).
Pretreatment with ANP abrogated PepG-induced activation of the
NFκB cascade, ICAM-1 and VCAM-1 expression and stimulation of Rho
signaling endpoints such as phosphorylation of MYPT and MLC
(Fig. 2BD).
PepG-induced activation of Rho signaling was linked to time-
dependent activation of Rho-speciﬁc guanine nucleotide exchange
factor (GEF), GEF-H1 (Fig. 2C), which was tested in pulldown assays
using beads with immobilized Rho G17A mutant as described in
Methods. PepG-induced GEF-H1 activation was observed after 6 and
24 h of PepG challenge and was suppressed by cell pretreatment with
ANP (Fig. 2CD). The next experiments tested effects of PepG and ANP
on the MT cytoskeleton.55
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as described in Methods. The amount of polymerized β-tubulin in MT pellets was determined3.3. ANP prevents PepG-induced peripheral MT disassembly
Effects of PepG and ANP on MT dynamics were examined by quan-
titative evaluation of β-tubulin andMT tip protein EB1 immunoreactiv-
ity at the peripheral areas of agonist-stimulated EC. Methanol-ﬁxed EC
were subjected to immunoﬂuorescence staining with corresponding
antibodies, and image analysis of peripheral β-tubulin and EB1 distri-
bution in control cells and EC treated with PepG with or without ANP
pretreatment was performed as described in Methods. The results
show decreased fraction of peripheral MT (Fig. 3A) and decreased
EB1 immunoreactivity (Fig. 3B) in PepG-challenged EC. Pretreatment
with ANP signiﬁcantly attenuated the PepG-induced decrease in pe-
ripheral MT content and EB1-positive MT growing ends, thus reﬂecting
protection against PepG-induced peripheral MT disassembly (Fig. 3,
right panel). Insets in Fig. 3A and B represent higher magniﬁcation im-
ages of microtubule network in the peripheral regions of control and
stimulated cells.
3.4. PepG and ANP exhibit opposite effects onMT stability, re-assembly and
stathmin phosphorylation
Treatment of EC with PepG decreased the fraction of acetylated tubu-
lin thus indicating a reduction of a pool of stableMT (Fig. 4A). In contrast,
ANP increased the levels of acetylated tubulin and the levels of stathmin
phosphorylated at S63, the site known to inactivate its MT-
destabilizing activity [35]. The pepG-induced decrease in acetylated tu-
bulin and phosphorylated stathmin levels was reversed by ANP co-55
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110 Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119treatment (Fig. 4B). The consequences of PepG and (ANP + PepG)
treatment on MT dynamics were next tested in experiments with
cold-induced MT disassembly and recovery after EC re-warming to
37 °C (Fig. 4C). In contrast to vehicle-treated cells, MT re-
polymerization in EC exposed to PepG was signiﬁcantly decreased.
Cell pretreatment with ANP prior to PepG challenge and the cold-
induced MT disassembly/reassembly step signiﬁcantly increased the
amount of polymerized β-tubulin which was monitored by western
blot analysis. These results link sensitization of PepG-stimulated EC to
cold-induced MT depolymerization and delayed MT recovery. Collec-
tively, these results support the mechanism of ANP-induced protection
of peripheral MT via stathmin phosphorylation.
3.5. Stathmin phosphorylation is essential for barrier protective and
anti-inﬂammatory effects of ANP against PepG
The role of stathmin phosphorylation in ANP-induced barrier protec-
tive and anti-inﬂammatory effects was directly tested using measure-
ments of transendothelial electrical resistance (TER) and western blot
analysis of inﬂammatory readout ICAM-1 and the Rho pathway moni-
tored by phospho-MLC levels. Overexpression of phosphorylation-
deﬁcient stathmin-S63A mutant markedly attenuated the ANP protec-
tive effect on PepG-induced EC permeability (Fig. 5A). Expression of
stathmin-S63A blocked the ANP attenuating effects on ICAM-1 expres-
sion, MLC phosphorylation andMT stabilization monitored by the levels
of acetylated tubulin (Fig. 5B). In contrast to non-transfected cells or cells
transfected with empty vector, immunoﬂuorescence staining revealed
lower peripheral microtubule density in pulmonary EC expressingB
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gether, these data suggest a critical role of stathmin phosphorylation in
mediation of barrier protective and anti-inﬂammatory effects of ANP
via control of MT dynamics.
3.6. Stathmin knockdown attenuates PepG-induced EC permeability,
inﬂammatory response and Rho signaling
Stathmin depletion in pulmonary EC using gene-speciﬁc siRNA
attenuated PepG-induced TER decline (Fig. 6A). Attenuation of
PepG-induced permeability by stathmin knockdown was further
conﬁrmed in experiments with measurement of EC monolayer per-
meability for ﬂuorescently labeled avidin (Fig. 6B). Stathmin knock-
down inhibited PepG-induced IkBα degradation and expression of
ICAM-1 observed after 4–10 h of PepG challenge (Fig. 6C). Stathmin
knockdown also attenuated PepG-induced GEF-H1 activation
(Fig. 6D) and phosphorylation of Rho-kinase effectors MYPT and
MLC (Fig. 6C).
3.7. Stathmin knockdown confers protection against PepG-induced
peripheral MT disassembly
Using a stathmin knockown approach, we studied in more detail
stathmin’s role in PepG-induced changes in MT dynamics and stability.
Stathmin knockdown preserved the pool of acetylated tubulin in PepG-
treated EC (Fig. 7A). Stathmin knockdown also prevented PepG-induced
disassembly of peripheralMT detected by immunoﬂuorescence staining
(Fig. 7B) and attenuated PepG-induced EC barrier disruption reﬂected55
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111Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119by formation of central actin stress ﬁbers and intercellular gaps
(Fig. 7C). Depletion of stathmin promoted the MT reassembly after
cold treatment of EC monolayers (Fig. 7D). Functional role of stathmin
and ANP-dependent stathmin phosphorylation was further evaluated
in an animal model of PepG-induced lung injury.
3.8. ANP protective effects against PepG-induced lung injury are associated
with increased levels of phospho-stathmin and acetylated tubulin
In the lungs, PepG induces acute pulmonary inﬂammation in a dose-
dependent way, characterized by neutrophilic inﬂux and IL-6 produc-
tion in the bronchoalveolar lavage ﬂuid [36]. For in vivo studies, the
PepG was administered intratracheally at 2.5 mg/kg, the dose relevant
to previous reports [36,37]. This dose causes sub-lethal lung injury
and represents conditions associated with bacterial pneumonia. Thefollowing experiments examined ANP effects in the murine model of
PepG-induced lung injury. One group was challenged with PepG for
24 h, while another PepG-stimulated group received concurrent ANP
administration. Control mice were treated with vehicle (saline solu-
tion). At the end of the experiment, lung injury was evaluated by mea-
surements of bronchoalveolar lavage (BAL) protein concentration, cell
count, measurements of Evans blue accumulation in the lung tissue
and histological analysis of lung sections. PepG instillation caused pro-
nounced lung inﬂammation with prominent increase in BAL protein
concentration cell counts. These effects were signiﬁcantly attenuated
by ANP (Fig. 8A).
The protective effects of ANP against PepG-induced lung vascular
leakwere further assessed bymeasurement of Evans blue accumulation
in the lung tissue. PepG induced noticeable Evans blue accumulation in
the lung parenchyma, which was suppressed by ANP co-treatment
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113Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119(Fig. 8B). Quantitative analysis of Evans blue-labeled albumin extrava-
sation further conﬁrmed these results. Histological analysis of lung tis-
sue showed alveolar wall thickening, increased leukocyte inﬁltration
into the lung interstitium and alveolar space of PepG-challenged
lungs. These effects were attenuated by ANP cotreatment (Fig. 8C).
Western blot analysis of lung tissue samples showed that ANP also at-
tenuated the PepG-induced ICAM-1 expression. Anti-inﬂammatory
and lung protective effects of ANPwere associatedwith increased levels
of phospho-stathmin and preservation of the acetylated tubulin pool,
the parameters reﬂecting increased stability of MT cytoskeleton
(Fig. 8D).
3.9. PepG-induced lung injury is exacerbated in ANP knockout mice
In comparison towild typemice, themicewith ANP knockout devel-
oped more prominent lung inﬂammation and vascular leak in response
to PepG challenge characterized by a 1.5-fold increase in BAL protein
content and a nearly 2-fold increase in total cell and neutrophil counts
in BAL (Fig. 9AB). Measurement of myeloperoxidase (MPO) activity in
the lung tissue was used as an additional parameter of neutrophilicB
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Methods. The amount of polymerized β-tubulin in MT pellets and supernatants was determinedactivation and inﬂammation. PepG induced a more pronounced in-
crease in MPO activity in ANP knockout mice, as compared to wild
type controls (Fig. 9C). Interestingly, western blot analysis demonstrat-
ed increased ICAM-1 expression but decreased levels of acetylated tu-
bulin in lung tissue samples from PepG-stimulated ANP knockout
mice in comparison to PepG-stimulated wild type controls (Fig. 9D).
All tests described above showed no signiﬁcant difference between un-
treated wild type and ANP knockout mice (data not shown). These data
strongly suggest that ANP plays a key role in modulation of ALI induced
by bacterial pathogens, and ANP protective effects involve stabilization
of the MT cytoskeleton. The role of stathmin in ANP-mediated protec-
tive effects in vivowas investigated in further experiments.
3.10. Stathmin exhibits protective effects against PepG-induced lung injury
in ANP knockout mice
A role for stathmin in the mechanisms of ANP-mediated lung protec-
tion against PepG-induced injury was directly tested by in vivo knock-
down of stathmin using a PEI-based siRNA delivery protocol [25].
Control injections were performed with nonspeciﬁc RNA duplexes.25
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in BAL samples of PepG-challenged ANP knockoutmice (Fig. 10A) and re-
duced the vascular leak detected by Evans Blue extravasation (Fig. 10B).
Histochemical evaluation of inﬂammatory cell inﬁltration in lung paren-
chyma conﬁrmed protective effects of stathmin knockdown against
PepG-induced lung injury (Fig. 10C). Stathmin knockdown reduced
ICAM-1 expression, but increased the tubulin acetylation levels in
PepG-challenged lungs (Fig. 10D, left panel). No difference inmorpholog-
ical lung structure or basal BAL parameterswas found between untreated
wild type or ANP knockoutmice (data not shown). Stathmin depletion in
the lungs after 72 h of transfection was conﬁrmed by western blot
(Fig. 10D, left panel) and qRT-PCR analysis of lung tissue samples
(Fig. 10D, right panel).
4. Discussion
Previous studies by our group have shown that stabilization of MT
mediated by PKA-induced stathmin phosphorylation attenuates
thrombin-induced rapid release of GEF-H1 from MT and thrombin
receptor-induced Rho activation of EC barrier disruptive Rho signaling
[38]. On the other hand, ANP-induced phosphorylation of GEF-H1 at
serine-885 mediated by Rac GTPase-activated serine/threonine kinase
PAK1 increased GEF-H1 binding to MT and attenuated GEF-H1-
dependent activation of Rho signaling in thrombin-stimulated cells
[39]. This mechanism has been further tested in the model of
thrombin-induced EC permeability and aseptic mouse two-hit modelof acute lung injury caused by high tidal volumemechanical ventilation
combined with injection of thrombin-receptor activating peptide [39].
The current study demonstrates for the ﬁrst time the MT-dependent
mechanism of ANP protection against inﬂammation caused by bacterial
pathogen. This is also the ﬁrst report of stathmin role in the inhibition
of inﬂammation via stathmin phosphorylation-dependent MT stabiliza-
tion. EC stimulation with the Gram-positive bacterial compound PepG
caused MT destabilization and partial disassembly reﬂected by the de-
creased pool of acetylated tubulin and diminished MT peripheral
growth. ANP treatment preserved the MT network and attenuated
inﬂammatory signaling activated by PepG. Interestingly, this study
showed the PepG-induced decrease in stathmin phosphorylation. In
contrast, EC barrier preservation and anti-inﬂammatory ANP effects
were associated with increased stathmin phosphorylation. Expression
of phosphorylation-deﬁcient stathmin-S63A mutant destabilized MT
in PepG-treated EC (as detected by decreased acetylated tubulin con-
tent), which led to exacerbation of PepG EC barrier dysfunction and fur-
ther activation of inﬂammatory signaling. Taken together, these results
suggest that inhibition of PepG-induced Rho, p38 and NFκB inﬂamma-
tory cascades is dependent on stabilization of MT and involves ANP-
induced stathmin phosphorylation.
MT-dependentmodulation of Rho signaling has a high impact on the
PepG-induced inﬂammatory cascade. In addition to direct effects on EC
permeability, PepG-induced activation of the GEF-H1 – Rho pathway
may stimulate transcription of pro-inﬂammatory genes, while inhibi-
tion of Rho has been shown to reduce expression of TNFα, CXC
115Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119chemokines, leukocyte inﬁltration, and endotoxin-induced lung edema
[40,41]. Pharmacological inhibition of Rho attenuates lung injury
caused by both Gram-negative and Gram-positive pathogens [18,37,55
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116 Y. Tian et al. / Biochimica et Biophysica Acta 1852 (2015) 104–119inﬂammatory and barrier protective effects by stimulating the periph-
eral MT growth, stabilizing existing MT and attenuating the activity of
MT-associated GEF-H1 leading to downregulation of Rho signaling.
However, stathmin-mediated MT stabilization may also downregulate
Rho-independent inﬂammatory mechanisms by sequestering other
MT-binding molecules participating in inﬂammatory pathways. This
possibility requires further investigation.55
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sponse to bacterial agents.
The current study shows exacerbation of PepG-induced lung injury,
inﬂammation and destabilization of MT cytoskeleton in ANP knockout
mice. Our data suggest that basal ANP levels or ANP elevation in ALI con-
ditions moderate the extent of lung injury, which may represent a nega-
tive feedback control of inﬂammation by endogenous ANP. Interestingly,
knockdownof stathmin signiﬁcantly improved lungvascular barrier func-
tion and parameters of inﬂammation in ANP knockoutmice. These effects
were associated with stabilization of the MT cytoskeleton (detected by
the increased pool of acetylated tubulin). These data support the
stathmin-microtubule-dependent mechanism of ANP-induced anti-
inﬂammatory effects and lung protection and suggest a new protein tar-
get for drug design.
Host response to bacterial pathogens during ALI is accompanied by
increased production of inﬂammatory cytokines. Among them, TNFα
induces capillary leak [50] and inhibition of alveolar ﬂuid clearance
[51]. Because ANP inhibits production of inﬂammatory cytokines
TNFα and IL-6 [52] and directly blocks TNFα-induced inﬂammatory sig-
naling [53], these effects may act in synergy with the MT-dependent
mechanism described in this study and further contribute to the ANP-
induced protection in ALI.
Stathmin is constitutively expressed in pulmonary vascular EC, but
its expression levels may be developmentally regulated in other tissues.
For example, stathmin expression is repressed during the post-natal
liver development, but required for hepatocyte regeneration [54] and
proliferation as opposed to differentiation [55]. These data suggest addi-
tional functions of stathmin beyond control of MT stability and have to
be taken into consideration for treatments using agents neutralizing
stathmin activity. It is also important to note that, in addition to
stathmin-dependent mechanisms of lung vascular barrier protection
and anti-inﬂammatory activities exhibited by ANP, ANP-induced eleva-
tion of cGMP in alveolar epithelium may reduce opening probability of
alveolar epithelial ENaC sodium channels [56] and exhibit negative ef-
fects on alveolar ﬂuid clearance capacity during ARDS [57]. Whether
stathmin-mediated MT dynamics is involved in these adverse effects
of ANP remains to be investigated.
In summary, the current study presents a novel paradigm of ANP-
induced attenuation of inﬂammation caused by Gram-positive
pathogens via stathmin-dependent stabilization of microtubules. We
demonstrate a newmechanism of lung vascular endothelial barrier dys-
function and lung inﬂammation enhanced by PepG-induced destabili-
zation of MT dynamics, which can be rescued by ANP acting to block
the stathmin - GEF-H1 axis of Rho signaling. We also show that exacer-
bation of ALI and lung vascular endothelial permeability caused by
Gram-positive pathogens in Nppa−/−mice can be rescued by stabili-
zation ofMT structure and stimulation ofMTperipheral growth through
molecular inhibition of stathmin. These studies advance our under-
standing of protective mechanisms induced by ANP in ALI conditions
and emphasize the importance of MT-associated signaling in regulation
of lung barrier and inﬂammation as a unifyingmechanismplaying a role
in a variety of pathological conditions.Acknowledgements
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